Biotechnology News and Research

RSS

Novel heart repair therapy could be in the pipeline

The success of a new and experimental stem cell treatment used in animals could lead to a novel heart repair therapy for heart attack patients.

27 Aug 2007

Networking in living cells may hold key to fighting diseases

Scientists in Manchester are working to change the social habits of living cells an innovation that could bring about cleaner and greener fuel and help fight diseases such as cancer and diabetes.

From The University of Manchester 24 Aug 2007

New target for the development of anti-influenza drugs

Scientists at Cure Lab, Inc., a biotechnology company based in Canton, Massachusetts, in collaboration with researchers at Boston University and Harvard Medical School have discovered a potential new target for the development of anti-influenza (flu) drugs, including those that may be effective against potentially pandemic influenza strains like H5N1.

17 Aug 2007

Sirtuin protein instrumental in fat production and metabolism

A new Joslin Diabetes Center-led study has identified a protein found in fat cells that may play a major role in how fat is produced and stored, offering a new target for treatments to prevent obesity and reduce the risk for type 2 diabetes.

17 Aug 2007

Cancer blocking gene discovered

Canadian scientists have discovered a gene that suppresses the growth of many cancerous tumours.

14 Aug 2007

New initiative to tackle animal diseases

Endemic animal diseases cost UK farmers, and indirectly consumers, hundreds of millions of pounds a year and cause significant animal welfare problems.

13 Aug 2007

Researchers turn mouse into factory for human liver cells

Oregon Health & Science University researchers have figured out how to turn a mouse into a factory for human liver cells that can be used to test how pharmaceuticals are metabolized.

11 Aug 2007

Scientists tackle gene doping in athletes

Gene doping has the potential to spawn athletes capable of out-running, out-jumping and out-cycling the strongest of champions.

7 Aug 2007

New drugs to combat bioterrorism

The University of Illinois at Chicago College of Pharmacy has received a grant from the U.S. Department of Defense to develop new drugs to combat agents of bioterrorism.

7 Aug 2007

Bill Gates digs deep in his pocket for AIDS

The University of Maryland has been awarded a grant worth $15 Million by the Bill & Melinda Gates Foundation to develop an HIV/AIDS vaccine.

1 Aug 2007

Insulin produced in genetically modified lettuce relieves diabetes in mice

Capsules of insulin produced in genetically modified lettuce could hold the key to restoring the body's ability to produce insulin and help millions of Americans who suffer from insulin-dependent diabetes, according to University of Central Florida biomedical researchers.

1 Aug 2007

Bio-engineered bladders a step closer to reality

Researchers at the University of York are using an understanding of the special cells that line the bladder to develop ways of restoring continence to patients with serious bladder conditions, including cancer.

31 Jul 2007

Call for EU to launch major project to map out all our proteins

Biologists still have no clear idea how many active genes there are coding for proteins in humans and other organisms, even though for some species the genomes have been completely sequenced.

26 Jul 2007

Biologic agents valuable treatment option for patients with inflammatory bowel disease

The use of biologic agents for the treatment of inflammatory bowel disease (IBD) may benefit patients, but doctors need to consider the potential associated side effects in determining treatment course, according to a consensus paper published in this month's issue of Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.

26 Jul 2007

New facility for biotechnology and life science companies

The University of Rochester Medical Center (URMC) has announced the dedication of a new facility that will support the development of early stage biotechnology and life science companies.

25 Jul 2007

CTRC enrolls first patients in study for sarcoma

The Cancer Therapy & Research Center Institute for Drug Development, in collaboration with Oncolytics Biotech Inc., a biotechnology company, has enrolled the first two patients in a new Phase II clinical study for patients with various types of sarcomas that have metastasized to the lung.

25 Jul 2007

Wyeth wins case of Lisa Dean v. Wyeth

Wyeth has announced that the jury in the case of Lisa Dean v. Wyeth in U.S. District Court found in favor of Wyeth.

23 Jul 2007

Koronis Pharmaceuticals issued U.S. patent for KP-1461 therapeutic in development for treatment of HIV

Koronis Pharmaceuticals, Inc. has announced the issuance of U.S. Patent No. 7,244,732 that discloses the composition of KP-1461 -- the Company's lead antiviral therapeutic currently in a Phase 2 trial for the treatment of human immunodeficiency virus (HIV) infection.

23 Jul 2007

Scientists invent novel low-viscosity gel for regenerating human tissue

University of Delaware scientists have invented a novel biomaterial with surprising antibacterial properties that can be injected as a low-viscosity gel into a wound where it rigidifies nearly on contact--opening the door to the possibility of delivering a targeted payload of cells and antibiotics to repair the damaged tissue.

19 Jul 2007

Research on proteases and pathological processes

A research group of the UAB Institute of Biotechnology and Biomedicine and the UAB Department of Biochemistry and Molecular Biology, directed by Francesc Xavier Aviles, is the coordinator of a European project aimed at studying proteases with fluorescent molecules that allow their monitoring in healthy and pathological situations.

18 Jul 2007